This article is more than 5 years old. Information may no longer be current.
VIDEO: SPRINT results show promise in treatment of hypertension, high BP
Click Here to Manage Email Alerts
ORLANDO, Fla. — Frank Sellke, MD, chief of the division of cardiothoracic surgery at the Warren Alpert Medical School of Brown University and Rhode Island Hospital, and chair of the Committee on Scientific Sessions Program for the American Heart Association, discusses the clinical implications and excitement surrounding the SPRINT trial results.
Conducted as a comparison between two strategies in the treatment of high BP and hypertension, the proposed 6-year trial was terminated when its results were found to be reasonably conclusive before the trial was completed.
“A lot of committees that write guidelines for the treatment of hypertension are trying to figure out how to include this trial in their guidelines,” Sellke said.
The significant improvement in the patients’ condition, which showed fewer adverse effects, was due to the trial working outside of the traditional guidelines of high BP treatment.
“Not only is it going to affect the guidelines, it’s going to really affect how doctors treat their patients with high [BP],” Sellke said.